"MCF-7 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)
| Descriptor ID |
D061986
|
| MeSH Number(s) |
A11.251.210.190.630
|
| Concept/Terms |
MCF-7 Cells- MCF-7 Cells
- Cell, MCF-7
- Cells, MCF-7
- MCF 7 Cells
- MCF-7 Cell
- MCF7 Cells
- Cell, MCF7
- Cells, MCF7
- MCF7 Cell
- Michigan Cancer Foundation 7 Cells
|
Below are MeSH descriptors whose meaning is more general than "MCF-7 Cells".
Below are MeSH descriptors whose meaning is more specific than "MCF-7 Cells".
This graph shows the total number of publications written about "MCF-7 Cells" by people in this website by year, and whether "MCF-7 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 13 | 13 |
| 2014 | 0 | 19 | 19 |
| 2015 | 0 | 13 | 13 |
| 2016 | 0 | 10 | 10 |
| 2017 | 0 | 12 | 12 |
| 2018 | 0 | 14 | 14 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 11 | 11 |
| 2021 | 0 | 7 | 7 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "MCF-7 Cells" by people in Profiles.
-
Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B. Hereditas. 2024 Dec 21; 161(1):53.
-
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts. Cell Commun Signal. 2024 Nov 14; 22(1):545.
-
Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel Therapeutic Combinations. Int J Mol Sci. 2024 Aug 26; 25(17).
-
A drug repurposing study identifies novel FOXM1 inhibitors with in vitro activity against breast cancer cells. Med Oncol. 2024 Jun 25; 41(8):188.
-
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells. Endocr Relat Cancer. 2023 11 01; 30(11).
-
Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. Cell Death Dis. 2023 08 18; 14(8):532.
-
Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer. Pharmacol Rep. 2022 Apr; 74(2):366-378.
-
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. Front Immunol. 2021; 12:765898.
-
Plant-Derived and Dietary Hydroxybenzoic Acids-A Comprehensive Study of Structural, Anti-/Pro-Oxidant, Lipophilic, Antimicrobial, and Cytotoxic Activity in MDA-MB-231 and MCF-7 Cell Lines. Nutrients. 2021 Sep 04; 13(9).
-
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nat Commun. 2021 09 01; 12(1):5217.